BioSpace News Archive

BLS Pharma, Inc. filed a complaint late last month against Genetronics, Inc. and Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Case No. 30-2019-01119045, for breaching a contract to supply a needle-free injection system that BLS Pharma was using to develop a drug-device combination (DDC) for testosterone replacement therapy.

EncounterCare Solutions (ECSL) Pink Sheets. EncounterCare Solutions is pleased to announce that the OTC has recently published comments to SEC’s recent proposal to Rule 151-02 which governs public quoting of securities on OTC QX, OTC QB, and pink numbers.

NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’) today announced its global development strategy for 2020 and beyond, following proof-of-concept (POC) and European market approval for NBTXR3 in locally advanced soft tissue sarcoma of the extremities and trunk wall (Brand Name: Hensify®) in 2019.

January is Cervical Health Awareness Month. In honor of this important national health awareness observance, Alameda Health System (AHS) and Alameda Alliance for Health (Alliance) are teaming up to encourage more than 10,000 women in Alameda County to come in for their annual cervical screening at any AHS Women’s Wellness Center.

World’s leading life sciences accelerator expands to New York City, beginning April 2020

The American Diabetes Association welcomes the 2020 Principal Officers and Board of Directors.